IRBESARTAN AUROVITAS

150MG TBL NOB 56

SÚKL code 0131439
Name of the product IRBESARTAN AUROVITAS 150 MG TABLETY
_MA_MEDICATION_DETAIL_INFO_MED_NAME i IRBESARTAN AUROVITAS
Supplement 150MG TBL NOB 56
Strenght 150MG
Pharmaceutical form Tablet
Package 56
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance IRBESARTAN (IRBESARTANUM)
ATC group C09CA04
ATC group name IRBESARTAN

Marketing authorisation information

Registration Number 58/ 497/16-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 08. 2018
MA Holder Aurovitas, Unipessoal, Lda., Carnaxide
MA Holder country PORTUGALSKO
Actual MA holder Aurovitas, spol. s r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list